Medline Inc. (MDLN)

Medline Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Net Income	1,268	1,200	234	-25
Depreciation & Amortization	1,083	1,059	1,121	1,033
Share-Based Compensation	-	61	78	64
Other Operating Activities	-823	-551	252	-885
Operating Cash Flow	1,528	1,769	1,685	187
Operating Cash Flow Growth	-	4.98%	801.07%	-
Capital Expenditures	-439	-364	-285	-254
Acquisitions	-	-1,126	-16	-17
Change in Investments	-	-3	-11	7
Investing Cash Flow	-1,330	-1,493	-312	-264
Dividends Paid	-	-1,518	-114	-23
Share Issuance / Repurchase	-	-20	-	-
Debt Issued / Paid	-	-63	-77	-61
Other Financing Activities	-2,289	-12	-	-
Financing Cash Flow	-2,289	-1,613	-191	-84
Net Cash Flow	-2,068	-1,335	1,186	-191
Free Cash Flow	1,089	1,405	1,400	-67
Free Cash Flow Growth	-	0.36%	-	-
Free Cash Flow Margin	4.08%	5.51%	6.03%	-0.31%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).